A Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AKI Undergoing Major Cardiovascular Surgery (QRK.004)

This study has been terminated.
(Lack of an available patient population)
Sponsor:
Information provided by:
Quark Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00683553
First received: May 21, 2008
Last updated: November 12, 2010
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2010
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)